Generalized pustular eruptions associated with oral terbinafine.
Bennett
M L
ML
Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157-1071, USA.
Jorizzo
J L
JL
White
W L
WL
D000935:Antifungal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001707:Biopsy, Needle; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis; D017719:Diabetic Foot / Q000175:diagnosis / Q000188:drug therapy*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000009:adverse effects* / Q000627:therapeutic use; D012075:Remission, Spontaneous; D017444:Skin Diseases, Papulosquamous / Q000139:chemically induced* / Q000473:pathology; D000077291:Terbinafine
D000935:Antifungal Agents; D009281:Naphthalenes; D000077291:Terbinafine